Skip to main content
OpenTrials

Clinical trial condition

Unresectable Differentiated Thyroid Gland Carcinoma

Explore clinical trials studying Unresectable Differentiated Thyroid Gland Carcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Unresectable Differentiated Thyroid Gland Carcinoma trial results

Completed

Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)

NCT02973997

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +38 more
Locations
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Torrance, California, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View Trial Details

Related conditions